Tweetorial #4: Acute Toxicities
Pre-Survey

Before you view this activity, please take this pre-assessment. Taking this pre-assessment does not immediately qualify learners to earn credit.

Certificates of credit will only be sent to learners who also receive a passing score on the post-test (separate from this survey), and fill out the evaluation form and application for credit.

Question Title

* 1. HCPs: What are your credentials?

MD/DO

Trainee/Fellow

Nurse

Pharmacist

Other (please specify)

Question Title

* 2. What is your community of practice?

Academic

Community

Other (please specify)

Question Title

* 3. What is your specialty?

Hematology

Oncology

Pathology

Radiology

Other (please specify)

Question Title

* 4. Which of the following is the leading cause of death in patients with #MultipleMyeloma?

Multiple myeloma

Infectious disease

Heart disease

Other cancer

Question Title

* 5. 72 yo/F dx w/ IgA MM. She will begin lymphodepletion with fludarabine and cyclophosphamide tomorrow prior to idecabtagene vicleucel infusion. Which of the following should be started to prevent infection?

Valganciclovir + dapsone

Acyclovir+posaconazole

Levofloxacin +fluconazole

Acyclovir +cotrimoxazole

Question Title

* 6. 63 yo/M on cycle 6 teclistamab. He received acyclovir & sulfamethoxazole/trimethoprim prophylaxis. He was hospitalized for streptococcus pneumoniae pneumonia & tx w/ cefepime. IgG level is 1.4 g/L. Which of the following should be added to his regimen?

Valganciclovir

IV immunoglobulin

Voriconazole

Vancomycin

Question Title

* 7. Please let us know who you are so we can connect your responses to your post-test & application to claim CME credit (completed after participating in the activity)

First & Last Name

State/Province

ZIP/Postal Code

Country

Email Address

Tweetorial #4: Acute Toxicities ***Pre-Survey***

Question Title

* 1. HCPs: What are your credentials?

Question Title

* 2. What is your community of practice?

Question Title

* 3. What is your specialty?

Question Title

* 4. Which of the following is the leading cause of death in patients with #MultipleMyeloma?

Question Title

* 5. 72 yo/F dx w/ IgA MM. She will begin lymphodepletion with fludarabine and cyclophosphamide tomorrow prior to idecabtagene vicleucel infusion. Which of the following should be started to prevent infection?

Question Title

* 6. 63 yo/M on cycle 6 teclistamab. He received acyclovir & sulfamethoxazole/trimethoprim prophylaxis. He was hospitalized for streptococcus pneumoniae pneumonia & tx w/ cefepime. IgG level is 1.4 g/L. Which of the following should be added to his regimen?

Question Title

* 7. Please let us know who you are so we can connect your responses to your post-test & application to claim CME credit (completed after participating in the activity)

Tweetorial #4: Acute Toxicities
Pre-Survey